Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Humira

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humira was produced by AbbVie and Eisai.

FDA approves AbbVie’s psoriasis blockbuster-to-be Skyrizi

FDA approves AbbVie’s psoriasis blockbuster-to-be Skyrizi

Two studies compared risankizumab to J&J’s $4bn-a-year IL-12/IL-23 inhibitor Stelara (ustekinumab) and one against its own TNF inhibitor Humira (adalimumab), currently the biggest-selling ... The approval builds on AbbVie’s immunology profile, which

Gilead and Galapagos close in on filing for Xeljanz rival

Gilead and Galapagos close in on filing for Xeljanz rival In FINCH 1, selective JAK1 inhibitor filgotinib was compared to AbbVie’s $18bn-a-year TNF antibody Humira (adalimumab) or placebo – given on top of generic disease-modifying antirheumatic drug (DMARD) ... of Humira which is given by injection.

Takeda’s Entyvio tops Humira in ulcerative colitis

Takeda’s Entyvio tops Humira in ulcerative colitis Entyvio is important for post-merger Takeda. Takeda’s key growth product Entyvio has outperformed AbbVie’s Humira in a trial in ulcerative colitis (UC), said to be the first ... The VARSITY study pitted anti-integrin antibody Entyvio (vedolizumab)

AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod

AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod Johnson’s Stelara (targeting IL-23 and IL-12) and AbbVie’s own ageing market leader Humira. ... The launch of Skyrizi in Europe is especially important for AbbVie as Humira is already losing revenue rapidly in the continent thanks to the arrival late

UCB looks to pipeline with five years left for twin blockbusters

UCB looks to pipeline with five years left for twin blockbusters The company’s phase 3 study (NCT03412747) is a three-arm study of bimekizumab, Humira and placebo, with data expected in the first half of 2019.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics